Author： Milone F.
Publisher： Informa Healthcare
ISSN： 1366-5804
Source： Biomarkers, Vol.18, Iss.2, 2013-03, pp. : 121-125
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
TGF-&bgr; signalling-related markers in cancer patients with bone metastasis
By Baselga Jose Rothenberg Mace L. Tabernero Josep Seoane Joan Daly Thomas Cleverly Ann Berry Brandi Rhoades Susanne K. Ray Chad A. Fill Jeffrey Farrington Daphne L. Anne Wallace Lisa Yingling Jonathan M. Lahn Michael Arteaga Carlos Carducci Michael
Biomarkers, Vol. 13, Iss. 2, 2008-05 ,pp. :
Access to resources
Recommend
Hypoxia: the tumor's gateway to progression along the angiogenic pathway
By Brahimi-Horn C. Berra E. Pouyssegur J.
Trends in Cell Biology, Vol. 11, Iss. 11, 2001-11 ,pp. :
Molecular target therapy for bone metastasis: starting a new era with denosumab, a RANKL inhibitor
By Rolfo Christian Raez Luis E Russo Antonio Reguart Noemí Campelo Rosario García Bronte Giuseppe Papadimitriou Kostantinos Silvestris Franco
Expert Opinion on Biological Therapy, Vol. 14, Iss. 1, 2014-01 ,pp. :